Molecular Formula | C20H15NO3 |
Molar Mass | 317.34 |
Density | 1.352±0.06 g/cm3(Predicted) |
Melting Point | 260-261 °C |
Boling Point | 562.9±50.0 °C(Predicted) |
pKa | 9.42±0.30(Predicted) |
Storage Condition | -20℃ |
Physical and Chemical Properties | Crystallization. Melting point> 260 ℃. |
In vitro study | Oxyphenisatin has been shown to have antiproliferative activity. Oxyphenisatin acetate (OXY, NSC 59687) is the pro-drug of oxyphenisatin. OXY inhibits the growth of the breast cancer cell lines MCF7, T47D, HS578T, and MDA-MB-468 (IC 50 =0.8, 0.6, 2.1, 1.8 μM). This effect is associated with selective inhibition of translation accompanied by rapid phosphorylation of the nutrient sensing eIF2α kinases, GCN2 and PERK. |
In vivo study | Toxicity studies demonstrate that mice tolerate IP administration of OXY at 300 mg/kg once daily or 200 mg/kg twice daily. Administration of OXY at 300 mg/kg IP once daily for 10 days results in significantly smaller tumors from day 33 to day 52. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 3.151 ml | 15.756 ml | 31.512 ml |
5 mM | 0.63 ml | 3.151 ml | 6.302 ml |
10 mM | 0.315 ml | 1.576 ml | 3.151 ml |
5 mM | 0.063 ml | 0.315 ml | 0.63 ml |
biological activity | Oxyphenisatin (Oxyphenisatin) is a laxative. Oxyphenisatin acetate is a prodrug of oxybifloxacin with anti-cancer activity. |
Use | an intermediate of triacetaminophen. |
production method | is prepared by condensation of indigo carmine with phenol in the presence of concentrated sulfuric acid. |